"Spoločnosť Medispektrum s.r.o. vznikla v roku 2005 s cieľom venovať sa metabolickým ochoreniam, predovšetkým cukrovke, obezite, vysokej hladine tukov, ktoré sa pre svoj vysoký nárast nazývajú aj epidémiou nášho tisícročia. Mnohé sú spojené so životným štýlom. Spoločným ukazovateľom je významné ovplyvnenie kvality a dĺžky života. Našim cieľom je spokojný klient, ktorému sa snažíme zlepšiť zdravotný stav na základe najnovších poznatkov medicíny, zdravej výživy a poskytnúť príjemné prostredie aj v priestoroch našej Diabetologickej a metabolickej ambulancie. Spoločnosť je zapojená do veľkých národných a nadnárodných projektov. O kvalite práce svedčia ocenenia, výsledky auditov a inšpekcií, mediálne vystúpenia, edukačná a publikačná činnosť."

During the past decade, MEDISPEKTRUM s.r.o. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MEDISPEKTRUM s.r.o." #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "MEDISPEKTRUM s.r.o." are "Diabetes Mellitus, Type 2" (1 trials), "Dyslipidemia" (1 trials), "Neuropathic Pain Associated With Diabetic Peripheral Neuropathy" (1 trials), "Nonalcoholic Fatty Liver Disease" (1 trials) and "Nonalcoholic Steatohepatitis With Liver Fibrosis" (1 trials). Many other conditions were trialed in "MEDISPEKTRUM s.r.o." in a lesser frequency.

Most popular intervention types in "MEDISPEKTRUM s.r.o." are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BAY1817080" (1 trials), "K-877" (1 trials), "PF-04937319 - 100mg" (1 trials) and "PF-04937319 - 20mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "MEDISPEKTRUM s.r.o." are 5 trials for "All" genders.

Currently, there are NaN active trials in "MEDISPEKTRUM s.r.o.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in MEDISPEKTRUM s.r.o., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MEDISPEKTRUM s.r.o., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".